End-to-end Capability Midas Pharma’s end-to-end capabilities across Starting Materials, APIs, finished products and devices create cross-selling opportunities for clients seeking a single partner to manage the full pharmaceutical value chain, reducing coordination complexity and time to market.

Sterile CDMO Strength A track record of collaborations in sterile injectables and pre-filled syringes, including Mithra and Onkokocsel partnerships, signals strong CDMO capabilities for fill-finish and device integration to support clients expanding into injectable products.

Global Footprint With multiple locations in major pharmaceutical markets and deep local know-how, Midas Pharma can support regional supply chains, regulatory navigation, and faster access to European and global markets for customers.

Quality Digitalization Adoption of TrackWise and Microsoft Power Platform indicates mature quality and data systems, presenting opportunities to partner on digital quality platforms, data integration, and end-to-end visibility across the supply chain.

Stable Partnership As a long-standing family-owned company with a proven track record coordinating complex projects, Midas Pharma offers reliability and ongoing development support for customers requiring compliant, long-term pharmaceutical manufacturing partnerships.